Omicron variant: the case for cautious optimism
The government is right to act quickly, but vaccines may still be effective – and evolution itself might act in our favour.
By
Michael Barrett
Michael Barrett is professor of biochemical parasitology at the University of Glasgow.
Latest articles
All Articles
Why herd immunity is not an option for the UK as it faces Covid-19
With less than 10 per cent of the UK population presumed immune, thousands of deaths will result without new rules.
By
The lesson of the antibiotics race: science must be ethical, not perverse
The Nazis’ barbaric testing of suplhur drugs during the Second World War is a warning from history.
By
Can you catch Covid-19 twice?
The question of how long our antibodies last will determine the future impact of the disease, and our response…
By
How do coronavirus tests work?
In the UK, a lack of testing has left us struggling to identify active cases of Covid-19. Developing a way to…
By
What makes us vulnerable to Covid-19
Why are some people worse affected by Covid-19 (and other viruses) than others? Estimates of the fatality rate vary…
By
How the UK can fight a coronavirus epidemic
The likelihood is that millions in the UK will become infected: schools should be closed and major gatherings cancelled.
By
Why the UK must now brace for a coronavirus epidemic
The discovery of hundreds of cases in Italy has made the spread of the disease in the UK almost inevitable.
By
Coronavirus shows why the world must urgently invest in epidemic preparedness
Funding from governments and the pharmaceutical industry to tackle infectious diseases has been waning for years.
By